Updates and Events

Dec. 1, 2023 A new paper published in Lupus Science & Medicine on the results of a study in China reported that a potential treatment telitacicept demonstrated favorable effectiveness and safety in patients with active SLE. It also improved effects of lupus on kidneys and the blood. Telitacicept is conditionally approved in China as a […] READ MORE

November, 2023 At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial data and breakthrough foundational research were presented. Following are highlights of work funded by the Lupus Research Alliance or supported in partnership with industry through our clinical affiliate Lupus Therapeutics. CAR-T Cell Therapy is […] READ MORE

New York, NY. November 21, 2023 – This year’s Lupus Research Alliance (LRA) Breaking Through Gala raised $2 million for lupus research and brought the hope of tremendous progress that’s improving lupus treatment while driving to a cure.  The annual celebration began with a powerhouse performance and moving tribute to lupus warriors by multi-talented pianist, […] READ MORE

November 14, 2023 Shanna Garcia’s Native American heritage as a Lipan Apache descendant dates back to the 1800’s when her family protected their tribal lands alongside the famous warrior Geronimo. Now her fight to resist the effects of lupus on herself and her people is just as fierce and passionate. In honor of Native American […] READ MORE

November 7, 2023 This October, the Lupus Research Alliance (LRA) held its annual scientific conference, Forum for Discovery, in New York City. This event serves as a pivotal gathering where LRA-funded researchers from across the globe convene to share their recent breakthroughs. Forum for Discovery serves as a catalyst, fostering interactions upon which further groundbreaking […] READ MORE

November 6, 2023 The New York City Marathon brings together 30,000 professional and amateur runners from around the world to NYC who have trained long hours to prepare for this iconic international event. For Laura Haley, Sarah Edwards, and Molly Supple, from Arizona, Oregon, and Spain, respectively, who met in college and bonded through running, […] READ MORE

This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part of, the American College of Rheumatology.  30+ presentations of studies funded by the LRA spanning a broad spectrum of research areas Positive results from Phase 2/3 clinical studies supported by LRA affiliate Lupus Therapeutics point to […] READ MORE

Are you, a family member or friend employed by the Federal Government? Anyone who is a current or retired federal, postal, or military employee can support the Lupus Research Alliance by making a pledge through the 2023 Combined Federal Campaign (CFC). Conveying how giving makes both recipients and donors feel, this year’s CFC campaign called […] READ MORE

NEW YORK, NY. Oct. 26. Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results of the Patient Advocates for Lupus Studies (PALS) pilot study were recently published in ACR Open Rheumatology , the official open-access journal of the American College of Rheumatology. The PALS (Patient Advocates […] READ MORE

NEW YORK, N.Y., Oct. 24 – Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announces a partnership with AbbVie Inc. for the Phase 3 clinical program of upadacitinib (RINVOQ®) in individuals living with systemic lupus erythematosus (SLE). In this partnership, Lupus Therapeutics will assist with study participant recruitment, site activation and engagement […] READ MORE

October, 2023 Amy, Jon, and Mary Kay Bottorff Lupus Warrior LRA Supporters & Friends When her daughter Amy was diagnosed with lupus, Mary Kay Bottorff searched for two years before deciding to support the Lupus Research Alliance (LRA). That’s because she and her husband Jon know the power of research.  They had seen what it can […] READ MORE

NEW YORK, N.Y. — October 17, 2023: Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced a partnership with Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing the engineered natural killer (NK) cell therapy NKX019 for refractory lupus nephritis that has not responded to standard treatment. Lupus Therapeutics has provided advisory […] READ MORE